We are live on ! Find out more
EVGN icon

Evogene

17 hedge funds and large institutions have $54.6M invested in Evogene in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

6% more funds holding

Funds holding: 1617 (+1)

5% more capital invested

Capital invested by funds: $52.2M → $54.6M (+$2.38M)

0.1% more ownership

Funds ownership: 2.34%2.44% (+0.1%)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
6
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

EVGN Hedge Fund Activity: Q2 2015 in Review

17 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q2 2015, worth a combined $54.6M — up 4.6% from $52.2M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new EVGN positions and 0 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Waddell & Reed Financial, adding an estimated $1.56M. The largest seller was Wellington Management Group, cutting an estimated $46K.

  • 17 institutional investors held Evogene (EVGN) as of Q2 2015, up from 16 in Q1 2015.
  • Funds reported $54.6M of Evogene stock for Q2 2015, up 4.6% quarter-over-quarter.
  • 1 fund opened new Evogene positions in Q2 2015 and 0 closed out, a net change of +1 holder.
  • The largest Evogene buyer in Q2 2015 was Waddell & Reed Financial, an estimated $1.56M added.
  • The largest Evogene seller in Q2 2015 was Wellington Management Group, an estimated $46K sold.

Based on aggregated 13F filings for Q2 2015.